ReviewPharmacoEconomics1994

Recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF): an appraisal of its pharmacoeconomic status in neutropenia associated with chemotherapy and autologous bone marrow transplant.

K L Goa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.